The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
08/27/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-RM-09-019
Opportunity Category:
Discretionary
Posted Date:
Aug 27, 2009
Creation Date:
Aug 27, 2009
Original Closing Date for Applications:
Jun 01, 2010
Current Closing Date for Applications:
Jun 01, 2010
Archive Date:
Jul 02, 2010
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Education
Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
$116,000,000
Award Ceiling:
Award Floor:
CFDA Number(s):
93.310
--
Trans-NIH Research Support
93.389
--
National Center for Research Resources
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Public and State controlled institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:
Other Eligible Applicants include the following:
This FOA is limited to current Clinical and Translational Science Award (CTSA) awardees and current or new collaborators. Because the Institutional CTSA program is focused on the development of a rigorous and robust academic discipline of clinical and translational science, the applicant institution(s) must include a graduate school accredited to award higher degrees in clinical research. Examples of acceptable higher degrees include MS and PhD in topics such as Clinical Research, Public Health, Pharmacology, Nursing and Epidemiology. Partnerships among schools of medicine, dentistry, nursing, pharmacy, osteopathy, public health, engineering and other clinically-related institutions are strongly encouraged, as is the inclusion of other relevant clinical research entities and organizations. The CTSA is expected to form an integrated institutional home that includes faculty committed to developing the discipline of clinical and translational science that will transcend multiple departments, schools, clinical and research institutes and hospitals. Therefore, an institution may submit only a single application in response to this FOA. Multiple applications from different divisions, faculties, centers, schools, etc. of the same university or medical school will be returned without further consideration by the NIH. Potential applicants whose existing and long-term affiliations will be disrupted by this rule must contact NIH Program Staff to determine whether they may be eligible for a waiver of the restriction. Foreign institutions are not allowed to apply for this program. Domestic institutions may use CTSA resources to support the foreign activities of projects that receive primary funding from DHHS. These activities are permitted under the UL1 and KL2 components of the CTSA only and may not include the pre-doctoral TL1 component. Appropriate clearances, a mentoring plan for any foreign training and approval by NIH Program Staff are required before the use of CTSA resources begins. Applications from ineligible institutions will not be reviewed. Applicants are encouraged to demonstrate significant institutional commitment when it is offered.
Agency Name
National Institutes of Health
Description
Purpose. This FOA invites current Clinical and Translational Science Award (CTSA) awardees to propose developments in their environments that will sustain and advance clinical and translational science as a distinct discipline. NIH resources will give institutions flexibility to develop their existing configuration, resources and talent to maximize the safety, efficiency, quality and speed of clinical and translational research. The academic home for clinical and translational science can be a center, department, or institute (C/D/I), and is expected to include faculty who conduct original research, develop graduate and postgraduate training curricula and lead programs that integrate clinical and translational science across multiple departments, schools, research institutes and hospitals.
Mechanism of Support. This FOA will utilize the NIH Specialized Center Cooperative Agreements (U54) mechanism.
Funds Available and Anticipated Number of Awards. The total funds available for the new awards are approximately $116 million. Up to 12 awards are anticipated from this solicitation. The NIH intends to issue solicitations for new and competing renewals of CTSAs annually. Awards will vary in size due to the prior consolidation of multiple programs at the applicant institution(s) into the CTSA program proposal. The annual total costs that may be requested have been communicated with potential applicants and may be verified by contacting NCRR Program Staff.
